Stabilin-2 (STAB2) is the primary clearance receptor controlling endocytic turnover of hyaluronan (HA), a key glycosaminoglycan of ECM that is associated with cell proliferation, invasion, angiogenesis, lymphocyte trafficking, and immune protection in GBM [27, 28]. Here, STAB2 is linked to glioblastoma.